Study S002040

What is the Effects of Incretin on the Blood Pressure and Lipid in Overweight or Obese Diabetes Patients With Masked Hypertension: Liraglutide Plus Mitiglinide Comparing Metformin Plus Mitiglinide or Mitiglinide Alone（BLOOD STUDY）

ClinicalTrials.gov record

Registration

Registration: NCT02503943
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 90
Start: 2015-05
Primary completion: 2016-09
Lead sponsor: Third Affiliated Hospital of Third Military Medical University
Conditions: Type 2 Diabetes; Overweight; Obesity; Masked Hypertension
Interventions: DRUG:"Liraglutide" and "Mitiglinide"; DRUG:"Metformin" and "Mitiglinide"; DRUG:"Mitiglinide"
Results posted: FALSE

Registered primary outcomes

Blood Pressure change [Baseline,4 weeks,8 weeks,12 weeks,16 weeks,20 weeks,up to 24 weeks]
Lipid profile (triglyceride, total cholesterol, LDL-c; HDL-c; mmol/L) change [Baseline,4 weeks,8 weeks,12 weeks,16 weeks,20 weeks,up to 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.